alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.a



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of American Affordable Housing II Limited Partnership (the "Partnership") on Form 10-Q for the period ended September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John P. Manning, Principal Executive Officer of the general partner of the general partner of the Partnership's general partner, C&M Management Inc., certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, after due inquiry:



|(1) | The Report fully complies with the requirements of section 13(a)-15 or 15(d)-15 of the Securities and Exchange Act of 1934; and                        
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                        
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Partnership.



|                  |     |                            
|----------------- | --- | ---------------------------
|Date:             |     |                            
|November 16, 2009 | By: | /s/ John P. Manning        
|                  |     |                            
|                  |     | John P. Manning            
|                  |     | Principal Executive Officer

A signed original of this written statement required by Section 906, or other

document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Fund and will be retained by the Fund and furnished to the Securities and Exchange Commission or its staff upon request.
# C_2015127EN.01002601.xml

| 20.4.2015 | EN | Official Journal of the European Union | C 127/26 |
| --- | --- | --- | --- |

20.4.2015

EN

Official Journal of the European Union

C 127/26

---

Judgment of the General Court of 27 February 2015 — Universal Utility International v OHIM (Greenworld)

(Case T-106/14) (1)

1

((Community trade mark - Application for Community word mark Greenworld - Absolute grounds for refusal - Descriptive character - Article 7(1)(c) of Regulation (EC) No 207/2009))

(2015/C 127/35)

Language of the case: German

Parties

Parties

Applicant: Universal Utility International GmbH & Co.KG (Kaarst, Germany) (represented by: J. Mietzel, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Greenworld) (represented by: M. Fischer, Agent)

Defendant:

Re:

Re:

Action against the decision of the Fourth Board of Appeal of OHIM of 13 December 2013 (Case R 1658/2013-4), concerning an application for registration of the word sign Greenworld as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | The action is dismissed; |
| --- | --- |

1.

The action is dismissed;

| 2. | Universal Utility International GmbH & Co. KG is ordered to pay the costs. |
| --- | --- |

2.

Universal Utility International GmbH & Co. KG is ordered to pay the costs.

---

(1)  OJ C 142, 12.5.2014.

1

---
§ 582.5431 Magnesium oxide. ( a ) *Product.* Magnesium oxide.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
§ 884.2730 Home uterine activity monitor. ( a ) *Identification.* A home uterine activity monitor (HUAM) is an electronic system for at home antepartum measurement of uterine contractions. The HUAM system comprises a tocotransducer and an at-home recorder. This device is intended for use in women with a previous preterm delivery to aid in the detection of preterm labor.
( b ) *Classification.* Class II (special controls); guidance document (Class II Special Controls Guidance for Home Uterine Activity Monitors).
[66 FR 14076, Mar. 9, 2001, as amended at 86 FR 20283, Apr. 19, 2021]
#### § 530.1 Scope.

This part applies to the extralabel use in an animal of any approved new animal drug or approved new human drug by or on the lawful order of a licensed veterinarian within the context of a valid veterinary-client-patient relationship.
**Exhibit 10.2**

 

**Summary of Long-Term Incentive Plan**

 

In fiscal 2003, the Board of Directors of Angeion Corporation adoptedthe Long-Term Incentive Plan (the “Plan”). The Plan provides for the payment of cash compensation to eligibleemployees, including the Company’s executive officers, upon achievement ofpredetermined targets.  Bonuses will bepaid if the Company achieves specified levels of earnings before interest,taxes, depreciation and amortization for the three-year period ending October31, 2005.  The Plan is incremental to anybonuses that may be earned under the 2005 Management Incentive Bonus Plan.

 

Under the Plan, Mr. Rodney A. Young, the Company’s Chief ExecutiveOfficer, is eligible to participate in the third year of the Plan.  Therefore, Mr. Young is eligible for a bonusranging from 35.0% to 130.0% of base salary, on a one-third proratedbasis.  Mr. Richard E Jahnke, the Company’sChief Executive Officer until he retired on October 31, 2004, is eligible toparticipate in the first two years of the Plan. Mr. Jahnke is eligible for a bonus ranging from 35.0% to 130.0% of basesalary, on a two-thirds prorated basis. The Company’s Chief Financial Officer, Dale H. Johnson, is eligible fora bonus ranging from 15.0% to 55.7% of base salary.

 

----
# C_2015398EN.01004601.xml

| 30.11.2015 | EN | Official Journal of the European Union | C 398/46 |
| --- | --- | --- | --- |

30.11.2015

EN

Official Journal of the European Union

C 398/46

---

Judgment of the General Court of 7 October 2015 — Sonova Holding v OHIM (Flex)

(Case T-187/14) (1)

1

((Community trade mark - Community word mark FLEX - Absolute grounds for refusal - Descriptive character - Article 7(1)(c) and Article 7(2) of Regulation (EC) No 207/2009))

(2015/C 398/58)

Language of the case: English

Parties

Parties

Applicant: Sonova Holding AG (Stäfa, Switzerland) (represented by: C. Hawkes, Solicitor)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: L. Rampini, acting as Agent)

Defendant:

Re:

Re:

Action brought against the decision of the Second Board of Appeal of OHIM of 12 December 2013 (Case R 357/2013-2), relating to an application for registration of the word sign FLEX as a community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Sonova Holding AG to pay the costs. |
| --- | --- |

2.

Orders Sonova Holding AG to pay the costs.

---

(1)  OJ C 151, 19.5.2014.

1

---
# C_2014245EN.01002901.xml

| 28.7.2014 | EN | Official Journal of the European Union | C 245/29 |
| --- | --- | --- | --- |

28.7.2014

EN

Official Journal of the European Union

C 245/29

---

Action brought on 4 June 2014 — Ingeperfil v Commission

(Case T-393/14)

2014/C 245/39

Language of the case: Spanish

Parties

Parties

Applicant: Ingeperfil, SL (Barcelona, Spain) (represented by: J.C. García Muñoz, J.I. Jiménez-Blanco Carrillo de Albornoz and J. Corral García, lawyers)

Applicant:

Defendant: European Commission

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order the Commission to pay all the costs incurred in the proceedings. |
| --- | --- |

—

order the Commission to pay all the costs incurred in the proceedings.

Pleas in law and main arguments

Pleas in law and main arguments

The pleas in law and main arguments are those put forward in Case T-392/14.

---
EXHIBIT 4.1

                                   RESOLUTIONS

      RESOLVED, that in payment for legal services provided to the Company by
Bruce J. Lurie from September 1, 2002 through March 31, 2003, the Company grants
350,000 shares of the Company's common stock to be registered in a registration
statement on Form S-8 to be filed with the Securities and Exchange Commission
("SEC") promptly after the Company becomes current in all of its filing
obligations under the Securities Exchange Act of 1934 (the "Exchange Act").

      RESOLVED, that in payment for legal services provided to the Company by
Myles J. Tralins from September 1, 2002 through March 31, 2003, the Company
grants 350,000 shares of the Company's common stock to be registered in a
registration statement on Form S-8 to be filed with the Securities and Exchange
Commission ("SEC") promptly after the Company becomes current in all of its
filing obligations under the Securities Exchange Act of 1934 (the "Exchange
Act").

      Dated: April 9, 2003
[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Pages 10313-10314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4728]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 16, 2009, and published in the Federal 
Register on October 28, 2009, (74 FR 55586), Lonza Riverside, 900 River 
Road, Conshohocken, Pennsylvania 19428, made application by renewal to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)...........  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
------------------------------------------------------------------------

    The company plans to manufacture bulk products for finished dosage 
units and distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Lonza Riverside to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Lonza Riverside to ensure

[[Page 10314]]

that the company's registration is consistent with the public interest. 
The investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-4728 Filed 3-4-10; 8:45 am]
BILLING CODE 4410-09-P
#### § 1.1382-6 Taxable income of cooperatives; treatment of earnings received after patronage occurred.

If earnings derived from business done with or for patrons are includible in the gross income of the cooperative organization for a taxable year after the taxable year during which the patronage occurred, then, for purposes of determining whether the cooperative is allowed a deduction under section 1382(b) and § 1.1382-2, the patronage to which these earnings relate shall be considered to have occurred during the taxable year for which such earnings are includible in the cooperative's gross income. Thus, if the cooperative organization pays these earnings out as patronage dividends during the payment period for the taxable year for which the earnings are includible in its gross income, it will be allowed a deduction for such payments under section 1382(b)(1) and paragraph (b) of § 1.1382-2, to the extent they are paid in money, qualified written notices of allocation, or other property (other than written notices of allocation).

[T.D. 6643, 28 FR 3156, Apr. 2, 1963]
# C_2014315EN.01006401.xml

| 15.9.2014 | EN | Official Journal of the European Union | C 315/64 |
| --- | --- | --- | --- |

15.9.2014

EN

Official Journal of the European Union

C 315/64

---

Order of the President of the General Court of 20 June 2014 — Wilders v Parliament and Council

(Case T-410/14 R)

((Interim measures - European Parliament - Act concerning the election of the Members of the European Parliament by direct universal suffrage - Incompatibility of the office of Member of the European Parliament with that of member of a national parliament (ban on holding a dual mandate) - Application for interim measures - Disregard of formal requirements - Manifest inadmissibility of the main action - Inadmissibility))

2014/C 315/107

Language of the case: Dutch

Parties

Parties

Applicant: Geert Wilders (represented by: G. Knoops and C. Hamburger, lawyers)

Applicant:

Defendants: European Parliament and Council of the European Union

Defendants:

Re:

Re:

Application for interim measures, essentially to permit the applicant to be officially sworn in as a member of the European Parliament, while continuing to hold the office of Member of the Netherlands Parliament

Operative part of the order

Operative part of the order

| 1. | The application for interim measures is dismissed. |
| --- | --- |

1.

The application for interim measures is dismissed.

| 2. | The costs are reserved. |
| --- | --- |

2.

The costs are reserved.

---
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.5540 Immunoglobulin G (Fd fragment specific) immunological test system. ( a ) *Identification.* An immunoglobulin G (Fd fragment specific) immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the amino terminal (antigen-binding) end (Fd fragment) of the heavy chain (a subunit) of the immunoglobulin antibody molecule in serum. Measurement of immunoglobulin G Fd fragments aids in the diagnosis of plasma antibody-forming cell abnormalities.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 59 FR 63007, Dec. 7, 1994; 66 FR 38793, July 25, 2001]
#### Peter Congiardo, Plaintiff-Appellee, v. Tony Bordenaro, Sr., and Tony Bordenaro, Jr., Defendants-Appellants.

Gen. No. 51,945.

First District, Fourth Division.

February 26, 1969.

*375James A. Thompson, of Chicago, for appellants; Arnold S. Root, of Chicago (Edward M. Platt, of counsel), for appellee.

Opinion by

PRESIDING JUSTICE DRUCKER.

Not to be published in full.
# C_2014135EN.01005702.xml

| 5.5.2014 | EN | Official Journal of the European Union | C 135/57 |
| --- | --- | --- | --- |

5.5.2014

EN

Official Journal of the European Union

C 135/57

---

Action brought on 3 March 2014 — EE v OHIM (Device of an ivory dotted pattern)

(Case T-144/14)

2014/C 135/75

Language of the case: English

Parties

Parties

Applicant: EE Ltd (Hatfield, United Kingdom) (represented by: P. Brownlow, Solicitor)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 7 January 2014 given in Case R 705/2013-1. |
| --- | --- |

—

Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 7 January 2014 given in Case R 705/2013-1.

Pleas in law and main arguments

Pleas in law and main arguments

Community trade mark concerned: The figurative trade mark representing a device of an ivory pattern for goods and services in Classes 7, 9, 16, 25, 35-39, 41, 42 and 45 — Community trade mark application No 11 388 493

Community trade mark concerned:

Decision of the Examiner: Found the mark applied for not eligible for registration

Decision of the Examiner:

Decision of the Board of Appeal: Dismissed the appeal

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 7(1)(b) CTMR.

Pleas in law:

---
### Page 1 of 3 **Disposition Comments Docket No:**  

### FAA - 2012 - 0689 These comments are in **Directorate ID:** 

### 2009 - SW - 065 - AD response to an SNPRM Originating Office Tracking No.: **Next Step:** FRAN SNPRM 

### N o C omments/Only

Supportive Comments Received

– If this box is checked, no signatures are required. 

### Has the reference d service information been revised since the NPRM was issued? I f ye s, lis t latest revision and attach a cop y. Note that changes beyond the scope of the previously published NPRM will require a new notice. Contact the Directorate focal point for guidance. Instructions: Summarize all comments **by issue** (not by commenter) and provide your recommended resolution of each issue. **All comments relating to the sam e issue should be discussed together.**  Do not list all of the issues from one commenter togeth er. If changes to the AD are required based on the comments received, explain why and describe in detail what change(s) you recommend. Reference FAA - IR- M - 8040.1C Chapter 9. **ISSUE 1:** Select one o

f the following : If other, explain : Commenter(s): What change to the AD action is requested? Why is the change requested or how is it justified? Do we agree? If **YES,** we agree because Make the following changes to the AD: If **PARTIALLY AGREE** , we agree with because We disagree with because

Make the following changes to the AD: If **NO** , we don’t agree because **ISSUE 2**  **:** Select one of the following :

If other, explain : Commenter(s): What change to the AD action is requested? Why is the change requested or how is it justified? Do we agree? If **YES,** we agree because Make the following changes to the AD: If **PARTIALLY AGREE** , we agree w ith because We disagree with because Make the following changes to the AD:

### Page 2 of 3

If **NO** , we don’t agree because **For additional issues, do uble**  **- click**  **here**

### Page 3 of 3 **S ignature Section**  Signature indicates concurrence with this action. Originating Office Tracking No.: **ASE** Printed Name **: Date** 

**Branch M anager**  **Date**
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

MICHAEL VICTOR ARBREE,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

No. 4D19-2199

[June 4, 2020]

Appeal from the Circuit Court for the Fifteenth Judicial Circuit, Palm 

Beach County; Rosemarie Scher, Judge; L.T. Case No. 50-2018-CF005322-AXXX-MB.

Antony P. Ryan, Regional Counsel, and Richard G. Bartmon, Assistant 

Regional Counsel, Office of Criminal Conflict and Civil Regional Counsel, 

Fourth District, West Palm Beach, for appellant.

Ashley Moody, Attorney General, Tallahassee, and Marc B. Hernandez, 

Assistant Attorney General, West Palm Beach, for appellee.

PER CURIAM.

Affirmed.

LEVINE, C.J., DAMOORGIAN and FORST, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7824 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7824

To direct the Office for Victims of Crime of the Department of Justice 
    to implement anti-trafficking recommendations of the Government 
                         Accountability Office.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 26, 2024

   Mr. Owens (for himself and Mr. Johnson of Georgia) introduced the 
  following bill; which was referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
To direct the Office for Victims of Crime of the Department of Justice 
    to implement anti-trafficking recommendations of the Government 
                         Accountability Office.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Preventing Child Trafficking Act of 
2024''.

SEC. 2. DEFINITIONS.

    In this Act, the term ``anti-trafficking recommendations'' means 
the recommendations set forth in the report of the Government 
Accountability Office entitled ``Child Trafficking: Addressing 
Challenges to Public Awareness and Survivor Support'', which was 
published on December 11, 2023.

SEC. 3. IMPLEMENTATION OF ANTI-TRAFFICKING PROGRAMS FOR CHILDREN.

    (a) In General.--Not later than 180 days after the date of the 
enactment of this Act, the Office for Victims of Crime of the 
Department of Justice, in coordination with the Office on Trafficking 
in Persons of the Administration for Children and Families, shall 
implement the anti-trafficking recommendations.
    (b) Report.--Not later than 60 days after the date on which the 
Office for Victims of Crime implements the anti-trafficking 
recommendations pursuant to subsection (a), the Director of the Office 
for Victims of Crime shall submit a report to the Committee on the 
Judiciary of the Senate and Committee on the Judiciary of the House of 
Representatives that explicitly describes the steps taken by the Office 
to complete such implementation.
                                 <all>
```
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.5100 Ophthalmic beta radiation source. ( a ) *Identification.* An ophthalmic beta radiation source is a device intended to apply superficial radiation to benign and malignant ocular growths.
( b ) *Classification.* Class II.
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.4115 Thermal cautery unit. ( a ) *Identification.* A thermal cautery unit is an AC-powered or battery-powered device intended for use during ocular surgery to coagulate tissue or arrest bleeding by heat conducted through a wire tip.
( b ) *Classification.* Class II.